Solve Therapeutics
Cambridge, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $120M
Overview
A genetic medicine company creating RNA therapeutics to treat the root cause of rare genetic diseases.
Rare DiseaseGenetics & GenomicsNeurology
Technology Platform
A platform for designing and optimizing RNA-based therapeutics to precisely target the genetic root cause of rare diseases.
Funding History
1Total raised:$120M
Venture$120M
Opportunities
Potential to develop high-impact, life-changing therapies for underserved patient populations with significant unmet need.
Risk Factors
Faces risks related to clinical validation in small patient populations and the challenges of drug delivery for genetic medicines.
Competitive Landscape
Operates in the specialized rare disease RNA therapeutics space, competing on target selection and delivery technology.